PD-1/L1

Delve into the world of PD-1/L1 in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on PD-1/L1 to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

AstraZeneca's Imfinzi Combo Cuts Death Risk 42% in Phase III VOLGA Trial – Landmark Perioperative Win in Muscle-Invasive Bladder Cancer
CompanyDrug

AstraZeneca’s Imfinzi Combo Cuts Death Risk 42% in Phase III VOLGA Trial – Landmark Perioperative Win in Muscle-Invasive Bladder Cancer

AstraZeneca plc (NYSE: AZN) presented high-level results from a prespecified interim analysis of the Phase III VOLGA clinical trial at the 2026 European Society for Medical Oncology (ESMO) Congress, showing…

InnoCare Pharma Q3 Revenue Surges 150.6% as Orelabrutinib Expansion Drives Turnaround to Profitability

InnoCare Pharma Q3 Revenue Surges 150.6% as Orelabrutinib Expansion Drives Turnaround to Profitability

Novartis Raises Full-Year Core Profit Guidance as Q3 Sales Grow 4% – Kisqali Surges 37% to Lead Priority Brands

Novartis Raises Full-Year Core Profit Guidance as Q3 Sales Grow 4% – Kisqali Surges 37% to Lead Priority Brands

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Daiichi Sankyo Doses First Patient in Global Phase III TROPION-Lung08 Study

CompanyDeals

Eli Lilly Ends License for Innovent’s Tyvyt Outside China

CompanyDrug

Henlius Completes First Dosing in Head-to-Head Study of PD-1 Inhibitor HanSiZhuang

CompanyDrug

Junshi Biosciences Files for UK Approval of PD-1 Inhibitor Tuoyi

CompanyDrug

Aosaikang’s ASKG915 Accepted for FDA Review, Targets Advanced Solid Tumors

CompanyDrug

Ascletis Pharma’s PD-L1 Inhibitor ASC61 Gains NMPA IND Approval

CompanyDrug

Akeso Biopharma’s AK112 Receives Two New Breakthrough Therapy Designations

Company

EQRx Shifts Strategy Amid FDA Feedback on China-Sourced Data

Show More